Ticker: NWP
Industry: pharmaceuticals
Starting Price: $10.00
Risk: medium
Expected Return: 20%
Beta: 0.25
New World Pharma is a small drug maker constantly seeking to develop new products. The company's research and development arm has discovered a couple successful drugs and pass.it's most popular product is Ossidex, a drug that helps people with obsessive-compulsive behaviors cure every everyday pains, such as the irrational urge to check lock doors repetitively. The company is based out of London, UK, with its main research facility in Zurich, Switzerland. It was founded in 1994 by Gordon Helmut, a Nobel prize winning scientist who holds 7 PhD's. The company stock is extremely volatile, as the drug development process is very long and uncertain. Many drugs do not make it through the approval process, and need to be written off as severe losses. On the other hand, successful patent application congealed years of monopolistic profits with the drug.
NWP wins prestigious innovation in pharma award
Effect: +45%
Prices of Gullibex are increased 30%
Effect: +26%
NWP reports record profits
Effect: +48%
NWP: Annual revenue falls short of management's forecasts
Effect: -34%
Controversy over NWP's marketing practices sparks public outcry
Effect: -11%
NWP: Quarterly revenue falls short of management's forecasts
Effect: -17%
NWP announces record profits
Effect: +55%
NWP's pioneering research in personalized medicine shows significant advancements
Effect: +55%
NWP's latest drug receives positive feedback in Phase II trials
Effect: +59%
NWP faces class-action lawsuit over alleged side effects of Ossidex
Effect: -54%
NWP wins prestigious innovation in pharma award
Effect: +41%
Rumors of a takeover bid involving NWP cause stocks to surge
Effect: +58%
NWP reports all-time high deficit
Effect: -19%
NWP opens new state-of-the-art research facility in city
Effect: +20%
NWP wins prestigious international healthcare award
Effect: +54%
Prices of NWP drug are increased 20%
Effect: +22%
NWP: Quarterly revenue misses management's forecasts
Effect: -33%
Large amount of research jobs cut at NWP
Effect: -34%
Gullibex laboratory tests have failed
Effect: -32%
NWP: Annual revenue misses analyst's expectations
Effect: -18%